Search research articles
Contact Us
Filters
Showing results (1-10 of 191) with videos related to
Page
of 20
Sort By:
Clinical Trials (London, England)
|
February 5, 2013
Uptake of novel statistical methods for early-phase clinical studies in the UK public sector
Thomas Jaki
Statistics in Medicine
|
December 9, 2008
One- and two-stage design proposals for a phase II trial comparing three active treatments with control using an ordered categorical endpoint
John Whitehead, Thomas Jaki
Pharmaceutical Statistics
|
April 21, 2016
Why are two mistakes not worse than one? A proposal for controlling the expected number of false claims
Thomas Jaki, Alice Parry
Statistics in Medicine
|
September 1, 2017
Simultaneous confidence regions for multivariate bioequivalence
Philip Pallmann, Thomas Jaki
Statistics in Medicine
|
November 3, 2016
Factorial versus multi-arm multi-stage designs for clinical trials with multiple treatments
Thomas Jaki, Despina Vasileiou
Journal of the Royal Statistical Society. Series C, Applied Statistics
|
April 23, 2019
An information theoretic phase I-II design for molecularly targeted agents that does not require an assumption of monotonicity
Pavel Mozgunov, Thomas Jaki
Statistics in Medicine
|
December 21, 2019
Improving safety of the continual reassessment method via a modified allocation rule
Pavel Mozgunov, Thomas Jaki
Pharmaceutical Statistics
|
June 15, 2018
Dose-escalation strategies which use subgroup information
Amy Cotterill, Thomas Jaki
Biometrical Journal. Biometrische Zeitschrift
|
July 13, 2019
A flexible design for advanced Phase I/II clinical trials with continuous efficacy endpoints
Pavel Mozgunov, Thomas Jaki
Journal of Computational Biology : a Journal of Computational Molecular Cell Biology
|
August 11, 2012
Recovering independent associations in genetics: a comparison
Matthew Sperrin, Thomas Jaki
Page
of 20
Search research articles
Search
Showing results (1-10 of 191) with videos related to
Sort By:
Page
of 20
Clinical Trials (London, England)
|
February 5, 2013
Uptake of novel statistical methods for early-phase clinical studies in the UK public sector
Thomas Jaki
Statistics in Medicine
|
December 9, 2008
One- and two-stage design proposals for a phase II trial comparing three active treatments with control using an ordered categorical endpoint
John Whitehead, Thomas Jaki
Pharmaceutical Statistics
|
April 21, 2016
Why are two mistakes not worse than one? A proposal for controlling the expected number of false claims
Thomas Jaki, Alice Parry
Statistics in Medicine
|
September 1, 2017
Simultaneous confidence regions for multivariate bioequivalence
Philip Pallmann, Thomas Jaki
Statistics in Medicine
|
November 3, 2016
Factorial versus multi-arm multi-stage designs for clinical trials with multiple treatments
Thomas Jaki, Despina Vasileiou
Journal of the Royal Statistical Society. Series C, Applied Statistics
|
April 23, 2019
An information theoretic phase I-II design for molecularly targeted agents that does not require an assumption of monotonicity
Pavel Mozgunov, Thomas Jaki
Statistics in Medicine
|
December 21, 2019
Improving safety of the continual reassessment method via a modified allocation rule
Pavel Mozgunov, Thomas Jaki
Pharmaceutical Statistics
|
June 15, 2018
Dose-escalation strategies which use subgroup information
Amy Cotterill, Thomas Jaki
Biometrical Journal. Biometrische Zeitschrift
|
July 13, 2019
A flexible design for advanced Phase I/II clinical trials with continuous efficacy endpoints
Pavel Mozgunov, Thomas Jaki
Journal of Computational Biology : a Journal of Computational Molecular Cell Biology
|
August 11, 2012
Recovering independent associations in genetics: a comparison
Matthew Sperrin, Thomas Jaki
Page
of 20